Overview

Desensitization of Renal Transplant Candidates

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Trial of the use of Myfortic to reduce anti-HLA alloantibody in patients waiting for renal transplantation.
Phase:
Phase 1
Details
Lead Sponsor:
University of Florida
Collaborator:
Novartis
Treatments:
Mycophenolate mofetil
Mycophenolic Acid